PMAIP1 and breast carcinoma: Subsequent immunohistochemistry staining and analysis of NOXA protein expression levels in our cohort of 55 breast cancer patients showed that three quarters of the samples (41/55) exhibited a downregulation in NOXA protein levels post-NAC confirming our findings of PAMIP1 gene expression analyses.